| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(19901101)66:9<1861::AID-CNCR2820660902>3.0.CO;2-I |
| P698 | PubMed publication ID | 2224782 |
| P2093 | author name string | M Rodríguez | |
| E Vélez-García | |||
| W Curran | |||
| M Mohiuddin | |||
| V A Marcial | |||
| J Crissman | |||
| J S Cooper | |||
| M al Sarraf | |||
| P A Mowry | |||
| T F Pajak | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cisplatin | Q412415 |
| squamous cell carcinoma | Q681817 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | 1861-1868 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17 | |
| P478 | volume | 66 |
| Q36125036 | A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC). |
| Q83640526 | A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer |
| Q43844206 | A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy |
| Q93136739 | A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma |
| Q54191456 | A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. |
| Q84836906 | Accelerated fractionation radiotherapy and late intensification with 2 intra-arterial cisplatin infusions for locally advanced head and neck squamous cell carcinoma |
| Q36165415 | Adjuvant treatment of locally-advanced head and neck tumours |
| Q26767046 | Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches |
| Q36304013 | Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? |
| Q57498202 | An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation |
| Q35694417 | Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma |
| Q33768197 | Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer |
| Q91840508 | Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches |
| Q46487251 | Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer |
| Q35113123 | Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin |
| Q84637878 | Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis |
| Q64086042 | Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives |
| Q56532858 | Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial |
| Q90320526 | Comparison of Functional Organ Preservation by Concomitant Boost Radiotherapy Versus Concurrent Chemoradiation in Locally Advanced Carcinoma of Larynx or Hypopharynx: A Prospective Randomized Study |
| Q31992287 | Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. |
| Q33500817 | Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors |
| Q81431788 | Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity |
| Q51765787 | Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer. |
| Q80686796 | Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53) |
| Q24186289 | Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma |
| Q24201507 | Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma |
| Q92141565 | Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis |
| Q43781930 | Concurrent chemotherapy and radiotherapy as initial treatment for stage II supraglottic squamous cell carcinoma |
| Q35991873 | Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy |
| Q43881544 | Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer |
| Q86822252 | Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer |
| Q38570137 | Distribution of surviving tumor cells after chemoradiotherapy in tongue and floor of mouth carcinomas |
| Q44202178 | Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma |
| Q73516877 | Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience |
| Q40939020 | Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer |
| Q35548689 | Feasibility and response of concurrent weekly docetaxel with radical radiotherapy in locally advanced head and neck squamous cell carcinoma |
| Q37271937 | Head and neck cancer: an evolving treatment paradigm |
| Q27851567 | Human papillomavirus and survival of patients with oropharyngeal cancer. |
| Q33363075 | Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer |
| Q44926859 | Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Long-term results including functional outcome |
| Q73311133 | Integration of chemotherapy into the definitive management of squamous cell head and neck cancer |
| Q39891439 | Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation |
| Q64077345 | NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4 |
| Q41001719 | Nasopharyngeal carcinoma in children: retrospective review of 50 patients |
| Q75211196 | Nasopharyngeal carcinoma in children: ten years' experience at the Tata Memorial Hospital, Mumbai |
| Q30833237 | Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma |
| Q35066525 | Organ preservation trials for laryngeal cancer |
| Q47131012 | Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis |
| Q45153299 | Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma |
| Q47623830 | Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. |
| Q73516155 | Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results |
| Q73370356 | Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial |
| Q77392330 | Radiation therapy, cisplatin and hyperthermia in combination in management of patients with carcinomas of the head and neck with N2 or N3 metastatic cervical lymph nodes |
| Q43266642 | Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck |
| Q27313572 | Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity |
| Q73889214 | Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients |
| Q67601796 | Results of surgical treatment of T3 and T4 tumors of the oral cavity and oropharynx |
| Q71714304 | Simultaneous carboplatin and radiotherapy for all stages of head and neck squamous cell carcinoma |
| Q40404006 | Surgical palliation of head and neck cancer |
| Q74157749 | Surgical treatment of squamous cell carcinoma of the base of tongue |
| Q35160763 | Targeted infusions of supradose Cisplatin with systemic neutralization for carcinomas invading the temporal bone |
| Q73661183 | The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck |
| Q80686769 | Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer |
| Q36378279 | Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. |
Search more.